Sort
23,748 grants matching “melanoma”
FATE OF TUMOR CELLS IN PULMONARY METASTASIS
$338,494Children'S Hospital Of Philadelphia · R01 · FY2003 · CA
Project 1: Personalized Adjuvant Immunotherapy for High-risk Colorectal Cancer.
$338,439Michael J Overman · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
$338,378David G Denardo · Washington University · R01 · FY2019 · CA
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
$338,377Mayumi Ito · New York University School Of Medicine · U54 · FY2024 · CA
A clinical decision support tool to understand the survival benefit of kidney transplantation in candidates with a history of cancer
$338,316Allyson Hart · Hennepin Healthcare Research Institute · R01 · FY2025 · DK
Focal Adhesion Kinase - Tumor Biology and Therapeutics
$338,244Timothy A Marlowe · University Of Arizona · R37 · FY2022 · CA
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
$338,233Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · CA
MULTI-EPITOPE MELANOMA PEPTIDE VACCINATION WITH GM-CSF
$338,200University Of Virginia Charlottesville · R21 · FY2003 · CA
A mouse model for UV-induced junctional melanoma
$338,200George Washington University · R01 · FY2004 · CA
VACCINES WITH MHC CLASS II-RESTRICTED MELANOMA PEPTIDES
$338,200University Of Virginia Charlottesville · R21 · FY2003 · CA
A mouse model for UV-induced junctional melanoma
$338,200George Washington University · R01 · FY2003 · CA
A mouse model for UV-induced junctional melanoma
$338,200George Washington University · R01 · FY2005 · CA
MULTI-EPITOPE MELANOMA PEPTIDE VACCINATION WITH GM-CSF
$338,200University Of Virginia Charlottesville · R21 · FY2004 · CA
VACCINES WITH MHC CLASS II-RESTRICTED MELANOMA PEPTIDES
$338,200University Of Virginia Charlottesville · R21 · FY2004 · CA
A mouse model for UV-induced junctional melanoma
$338,200George Washington University · R01 · FY2002 · CA
Core B Proteomics & Biostatistics
$338,106Lee M Graves · Univ Of North Carolina Chapel Hill · P01 · FY2017 · CA
Targeting Abl kinases in BRAF-driven melanomas
$338,028Rina Plattner · University Of Kentucky · R01 · FY2019 · CA
Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy
$337,982Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
The GPR171 pathway in cancer immunotherapy
$337,922Yuwen Zhu · University Of Colorado Denver · R01 · FY2024 · CA
Melanoma Immunotherapy with GPR182 blockade
$337,922Yuwen Zhu · University Of Colorado Denver · R01 · FY2024 · CA
The CD93 pathway and melanoma therapy
$337,922Yuwen Zhu · University Of Colorado Denver · R01 · FY2024 · CA
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
$337,751Georg T Wondrak · University Of Arizona · R01 · FY2021 · CA
Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy
$337,726Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Multifunctional nanoparticles for targeting aberrant tumorigenic pathways
$337,720Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2013 · CA
Administration and Coordination Core
$337,707Gaudenz Danuser · Ut Southwestern Medical Center · U54 · FY2021 · CA